IBM Total Current Liabilities

IBM · Total Current Liabilities

IBM logo

IBM Total Current Liabilities

Latest reported$35.91B
IBM Quarterly Current Liabilities ($11.43B → $35.91B)
High-resolution chart · PNG

IBM total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

IBM Total Current Liabilities — Quarterly (USD)
Period endingTotal Current Liabilities (USD)
35,912,000,000
40,101,000,000
38,658,000,000
35,142,000,000
37,726,000,000
35,106,000,000
33,142,000,000
28,853,000,000
29,648,000,000
32,397,000,000
34,122,000,000
30,606,000,000
32,513,000,000
30,993,000,000
31,505,000,000
30,466,000,000
31,844,000,000
34,056,000,000
33,619,000,000
35,832,000,000
36,616,000,000
36,542,000,000
39,869,000,000
37,993,000,000
38,442,000,000
40,673,000,000
37,701,000,000
35,066,000,000
42,351,000,000
38,871,000,000
38,227,000,000
36,822,000,000
35,442,000,000
35,733,000,000
37,363,000,000
31,697,000,000
35,966,000,000
36,481,000,000
36,275,000,000
34,447,000,000
33,585,000,000
34,664,000,000
34,269,000,000
33,732,000,000
35,535,000,000
35,640,000,000
39,581,000,000
42,306,000,000
42,433,000,000
41,058,000,000
40,154,000,000
39,222,000,000
41,037,000,000
42,122,000,000
43,625,000,000
39,499,000,000
38,903,000,000
38,209,000,000
42,123,000,000
36,028,000,000
39,843,000,000
40,387,000,000
40,562,000,000
35,443,000,000
34,993,000,000
34,576,000,000
36,002,000,000
32,960,000,000
36,430,000,000
37,425,000,000
42,435,000,000
44,752,000,000
44,683,000,000
47,048,000,000
44,310,000,000
45,011,000,000
48,084,000,000
36,763,000,000
40,091,000,000
34,929,000,000
34,118,000,000
33,268,000,000
35,152,000,000
29,964,000,000
32,197,000,000
33,822,000,000
39,786,000,000
35,167,000,000
34,357,000,000
35,385,000,000
37,623,000,000
32,596,000,000
31,511,000,000
31,786,000,000
34,550,000,000
30,239,000,000
32,597,000,000
30,084,000,000
35,119,000,000
32,876,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.